These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24012702)

  • 1. Incorporation of quercetin in respirable lipid microparticles: effect on stability and cellular uptake on A549 pulmonary alveolar epithelial cells.
    Scalia S; Trotta V; Traini D; Young PM; Sticozzi C; Cervellati F; Valacchi G
    Colloids Surf B Biointerfaces; 2013 Dec; 112():322-9. PubMed ID: 24012702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy.
    Scalia S; Salama R; Young P; Traini D
    J Microencapsul; 2012; 29(3):225-33. PubMed ID: 22208706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of quercetin in lipid microparticles: effect on photo- and chemical-stability.
    Scalia S; Mezzena M
    J Pharm Biomed Anal; 2009 Jan; 49(1):90-4. PubMed ID: 19042102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery.
    Scalia S; Haghi M; Losi V; Trotta V; Young PM; Traini D
    Eur J Pharm Sci; 2013 May; 49(2):278-85. PubMed ID: 23541500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the in vitro penetration of quercetin through pig skin by combined microneedles and lipid microparticles.
    Paleco R; Vučen SR; Crean AM; Moore A; Scalia S
    Int J Pharm; 2014 Sep; 472(1-2):206-13. PubMed ID: 24928134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
    Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
    Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles.
    Nafee N; Gaber DM; Elzoghby AO; Helmy MW; Abdallah OY
    Pharm Res; 2020 Apr; 37(4):82. PubMed ID: 32291520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide.
    Hatahet T; Morille M; Shamseddin A; Aubert-Pouëssel A; Devoisselle JM; Bégu S
    Int J Pharm; 2017 Feb; 518(1-2):167-176. PubMed ID: 28011344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of solid lipid microparticle carriers on skin penetration of the sunscreen agent, 4-methylbenzylidene camphor.
    Scalia S; Mezzena M; Iannuccelli V
    J Pharm Pharmacol; 2007 Dec; 59(12):1621-7. PubMed ID: 18053323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of in vivo human skin penetration of resveratrol by chitosan-coated lipid microparticles.
    Scalia S; Trotta V; Iannuccelli V; Bianchi A
    Colloids Surf B Biointerfaces; 2015 Nov; 135():42-49. PubMed ID: 26241915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the inhalable quercetin loaded nanoemulsion for pulmonary delivery.
    Arbain NH; Salim N; Masoumi HRF; Wong TW; Basri M; Abdul Rahman MB
    Drug Deliv Transl Res; 2019 Apr; 9(2):497-507. PubMed ID: 29541999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles.
    Scalia S; Traini D; Young PM; Di Sabatino M; Passerini N; Albertini B
    Pharm Dev Technol; 2013 Feb; 18(1):266-73. PubMed ID: 22998063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential bioreactivity of neutral, cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cells.
    Ruenraroengsak P; Tetley TD
    Part Fibre Toxicol; 2015 Jul; 12():19. PubMed ID: 26133975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
    Manca ML; Cassano R; Valenti D; Trombino S; Ferrarelli T; Picci N; Fadda AM; Manconi M
    J Pharm Pharmacol; 2013 Sep; 65(9):1302-11. PubMed ID: 23927468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro.
    Sun M; Nie S; Pan X; Zhang R; Fan Z; Wang S
    Colloids Surf B Biointerfaces; 2014 Jan; 113():15-24. PubMed ID: 24060926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance.
    Patil-Gadhe A; Kyadarkunte A; Patole M; Pokharkar V
    Eur J Pharm Biopharm; 2014 Sep; 88(1):169-77. PubMed ID: 25078860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of different vitamin E carriers intended for pulmonary drug delivery.
    Laouini A; Andrieu V; Vecellio L; Fessi H; Charcosset C
    Int J Pharm; 2014 Aug; 471(1-2):385-90. PubMed ID: 24939617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of
    Scalia S; Zampino MR; Trotta V; Bianchi A
    Pharmazie; 2017 Apr; 72(4):200-204. PubMed ID: 29441987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems.
    Bose S; Du Y; Takhistov P; Michniak-Kohn B
    Int J Pharm; 2013 Jan; 441(1-2):56-66. PubMed ID: 23262430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of Quercetin Loaded Microparticles and their Antitumor Activity against Human Lung Cancer Cells (A549) in vitro.
    Li C; Gao L; Zhang Y; Simpson BK
    Curr Pharm Biotechnol; 2019; 20(11):945-954. PubMed ID: 31264544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.